Last reviewed: June 23, 2026
Last updated: June 23, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy for weight loss follows a careful escalation protocol, beginning with microdoses as low as 0.25 mg per week and advancing based on individual tolerance and metabolic response. The minimum starting dose is designed to minimize side effects while establishing the medication's effectiveness in your body. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, with pricing that remains flat regardless of your dose progression.
Understanding Semaglutide Starting Doses for Weight Loss
The lowest clinically meaningful semaglutide dose for weight loss sits between 0.25 mg and 0.5 mg per week, administered as a subcutaneous injection. This entry-level dosing activates GLP-1 receptors throughout your digestive system, slowing gastric emptying and increasing satiety signals to your brain. Research shows that even at these minimal doses, patients experience meaningful appetite reduction within the first 2–3 weeks of treatment.
Your body's initial response to semaglutide depends on factors like baseline metabolic rate, insulin sensitivity, and genetic predispositions in your GLP-1 receptor pathway. PlexusDx can identify your peptide-pathway genetic profile through the Precision Peptide Genetic Test, which examines 14 metabolic pathways and 150+ genetic insights to predict your dose-response trajectory. This personalized approach helps your healthcare provider establish the right starting point without guesswork.
How Semaglutide Dose Titration Works Over Time
Standard semaglutide escalation increases your dose by 0.25 mg each week until you reach an effective maintenance level, typically between 1.0 mg and 2.4 mg weekly. This gradual titration schedule—sometimes called the ramp-up protocol—allows your gastrointestinal system to adapt, reducing nausea and other adjustment-phase side effects. Most patients complete their dose escalation within 4–8 weeks, though individual timelines vary based on tolerance and weight loss goals.
PlexusDx maintains one flat monthly price for semaglutide injections across all doses, so your commitment tier price ($149–$189 per month depending on your selected plan) covers both your starting 0.25 mg dose and your eventual maintenance dose. This pricing structure removes financial uncertainty from the titration process and ensures you're never paying more as your clinician adjusts your therapy upward.
Minimum Effective Dose vs. Therapeutic Dose for Weight Loss
The minimum effective dose—the lowest amount that produces measurable weight loss—differs from the minimum starting dose. While 0.25 mg initiates receptor activation, most patients require 1.0 mg or higher weekly to achieve clinically significant body weight reduction of 5–10% over 12 weeks. However, some individuals with genetic variants in the GLP1R gene (rs6923761) or FTO gene (rs9939609) show robust responses at lower doses and plateau earlier.
PlexusDx's Precision Peptide Genetic Test identifies these genetic markers to help your provider predict whether you'll need a lower or higher maintenance dose for optimal results. Patients with certain peptide-pathway signatures may experience maximum benefit at 1.0–1.5 mg weekly, while others require 2.0–2.4 mg to achieve their weight loss targets. Starting at the minimum dose and titrating based on your personal response ensures you reach effectiveness without unnecessary exposure.
Side Effects at Low Semaglutide Doses and Tolerance Building
Gastrointestinal side effects—nausea, vomiting, constipation, and abdominal discomfort—occur most commonly during the first 1–2 weeks and typically improve as your body adapts. Beginning at the minimum 0.25 mg dose significantly reduces early side effect intensity compared to higher starting doses. Most patients report minimal to mild nausea at entry-level doses, allowing them to continue work and daily activities without interruption.
Your tolerance improves with each weekly increment, meaning side effects may briefly worsen when you increase to the next dose tier but resolve within several days. PlexusDx recommends discussing your side effect experience with your healthcare provider, as slower titration schedules or dose adjustments are available if needed. The Precision Peptide Genetic Test can also reveal genetic predispositions to gastrointestinal sensitivity, helping your clinician customize your escalation pace for maximum comfort.
Comparing Semaglutide to Other GLP-1 and Dual-Action Options
Semaglutide is a pure GLP-1 receptor agonist, meaning it targets one metabolic pathway. Tirzepatide, another compounded option from PlexusDx, activates both GLP-1 and GIP receptors and typically shows weight loss results at lower dose equivalents. If you're a candidate for dual-pathway therapy, tirzepatide often starts at 2.5 mg weekly and may produce similar or greater weight loss with a shorter titration schedule.
PlexusDx also offers GLP-Squared Injection, a dual compound combining semaglutide and tirzepatide in one injection, starting at $249 per month. Patients who don't achieve desired results on semaglutide alone or who have genetic variants in the GIPR pathway (rs1800437) may benefit from tirzepatide's dual-action mechanism. Your healthcare provider can discuss these options during your initial consultation, and genetic testing clarifies which pathway activation matters most for your metabolism.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the absolute minimum starting dose of semaglutide for weight loss?
The lowest standard starting dose is 0.25 mg per week via subcutaneous injection. Some clinicians prescribe microdose protocols as low as 0.1–0.15 mg to further minimize early side effects, though 0.25 mg is the most common entry point. PlexusDx also offers a Microdose GLP-1 Protocol at $129 per month for those seeking ultra-conservative initial dosing.
How long does it take to feel semaglutide working at the minimum dose?
Most patients notice reduced appetite and increased fullness within 3–7 days of their first 0.25 mg injection. Weight loss typically becomes measurable (1–2 pounds) by week 2–3, though some people see changes within the first week. Individual timelines depend on baseline metabolism and genetic GLP-1 receptor sensitivity.
Will my price increase if my semaglutide dose goes up?
No. PlexusDx pricing is completely flat across all dose levels. Your compounded semaglutide injection costs $149–$189 per month depending on your selected commitment tier, whether you're at 0.25 mg or 2.4 mg weekly. Your dose may need to go up. Your price won't.
Can I stay on the minimum semaglutide dose indefinitely?
Some patients plateau on weight loss at lower doses and choose to maintain their results without further escalation. However, most people require dose increases to continue losing weight, as the body can develop tolerance over 8–12 weeks. Your healthcare provider will monitor your progress and recommend adjustments if weight loss stalls.
Does the Precision Peptide Genetic Test predict my ideal starting dose?
Yes. PlexusDx's Precision Peptide Genetic Test examines your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways, revealing whether you're likely to respond well at lower doses or need higher escalation. This $99 add-on test (after your first month of treatment) helps your clinician personalize your starting dose and predict your maintenance range, reducing trial-and-error dosing.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss Medications: Can I Take Phentermine and Ozempic Together?
Decoding Zepbound: How Long Does It Take to Start Working for Sustainable Weight Loss?